Daniela Taranu

7PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesSpeech pathologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 24, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study.

Stefan Buchka, Alexander Hapfelmeier, Jan S Kirschke

|Aug 28, 2025
Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.

Luisa T Balz, Ingo Uttner, Daniela Taranu

|Jul 29, 2025
Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust.

Luisa T Balz, Ingo Uttner, Jochen Weishaupt

|May 14, 2025
Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a one-year follow-up study.

Daniela Taranu, Luisa T Balz, Jill Holbrook

|Apr 28, 2025
Plasma Exchange vs. Immunoadsorption: Effects on Immunological Markers and Predictive Value in Steroid-Refractory MS Attacks.

Ioannis Vardakas, Johannes Dorst, André Huss

|May 03, 2024
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid-refractory multiple sclerosis relapses.

Ioannis Vardakas, Johannes Dorst, André Huss

Pageof 2

Frequent Collaborators

5 joint publications

Hayrettin Tumani

5 joint publications

Ioannis Vardakas

3 joint publications

Makbule Senel

2 joint publications

Herbert Schreiber